Latest filing published 30 Jan 2008 for MGI PHARMA INC.
No signal scores available.
Eric P. Loukas discloses dealings in MGI Pharma Inc to SEC (Form 4). Over a trading history stretching from 3 October 2005 to 28 January 2008, the count stands at 12 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 30 January 2008 with a share grant in MGI Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations